LBX1 and non-small cell lung carcinoma: Epigenome-wide analysis has demonstrated that homeobox genes can act as potential DNA methylation markers for the early diagnosis of lung cancer.41 Moreover, Sandoval et al42 identified a hypermethylated five-gene signature associated with shorter relapse-free survival times of patients with stage I NSCLC without adjuvant chemotherapy.